- Home
- CBRL vs BBNX Comparison
CBRL vs BBNX Comparison
Compare CBRL & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBRL
- BBNX
- Stock Information
- Founded
- CBRL 1969
- BBNX 2015
- Country
- CBRL United States
- BBNX United States
- Employees
- CBRL N/A
- BBNX N/A
- Industry
- CBRL Restaurants
- BBNX Medical/Dental Instruments
- Sector
- CBRL Consumer Discretionary
- BBNX Health Care
- Exchange
- CBRL Nasdaq
- BBNX Nasdaq
- Market Cap
- CBRL 882.3M
- BBNX 967.6M
- IPO Year
- CBRL N/A
- BBNX 2025
- Fundamental
- Price
- CBRL $33.51
- BBNX $26.78
- Analyst Decision
- CBRL Hold
- BBNX Strong Buy
- Analyst Count
- CBRL 10
- BBNX 11
- Target Price
- CBRL $51.00
- BBNX $28.09
- AVG Volume (30 Days)
- CBRL 1.1M
- BBNX 670.5K
- Earning Date
- CBRL 12-05-2025
- BBNX 10-28-2025
- Dividend Yield
- CBRL 2.79%
- BBNX N/A
- EPS Growth
- CBRL 12.57
- BBNX N/A
- EPS
- CBRL 2.06
- BBNX N/A
- Revenue
- CBRL $3,483,684,000.00
- BBNX $88,570,000.00
- Revenue This Year
- CBRL N/A
- BBNX $43.04
- Revenue Next Year
- CBRL $3.17
- BBNX $35.60
- P/E Ratio
- CBRL $16.83
- BBNX N/A
- Revenue Growth
- CBRL 0.37
- BBNX 67.01
- 52 Week Low
- CBRL $33.86
- BBNX $8.89
- 52 Week High
- CBRL $71.93
- BBNX $30.47
- Technical
- Relative Strength Index (RSI)
- CBRL 22.86
- BBNX 67.98
- Support Level
- CBRL $35.76
- BBNX $19.52
- Resistance Level
- CBRL $37.21
- BBNX $30.47
- Average True Range (ATR)
- CBRL 1.52
- BBNX 1.62
- MACD
- CBRL -0.09
- BBNX 0.57
- Stochastic Oscillator
- CBRL 4.91
- BBNX 61.38
About CBRL Cracker Barrel Old Country Store Inc
Cracker Barrel Old Country Store Inc operates hundreds of full-service restaurants throughout the United States. The Cracker Barrel stores consists of a restaurant with a gift shop. The restaurants serve breakfast, lunch and dinner. The gift shop offers a variety of decorative and functional items specializing in rocking chairs, holiday gifts, toys, apparel and foods.
About BBNX Beta Bionics Inc. Common Stock
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.